Royal Philips Electronics launches CoughAssist E70 airway secretion management tool
New device can be used to clear secretions from the lungs by simulating a natural cough in adults and children
Royal Philips Electronics has launched the new CoughAssist E70, a comprehensive airway secretion management tool that offers a gentle alternative to traditional suctioning methods for adult and paediatric patients who are unable to cough or clear secretions effectively.
With many diseases, a weakened ability to cough and remove secretions increases the chance of infection. The use of CoughAssist has been shown in trials to significantly reduce hospitalisation rates for respiratory complications of neuromuscular disease.
A mechanical in-exsufflation device, CoughAssist clears secretions from the lungs by simulating a natural cough, gradually applying positive pressure to the airway and then rapidly shifting to negative pressure. Air is delivered through a facemask, a mouthpiece, or through a simple adapter to tracheostomy or an endotracheal tube.
“We are committed to working with physicians and the entire care team as allies for better patient care,” said Erik Hollander, global head of marketing at Philips Home Healthcare Solutions. “We have solutions that support every step of the patient care pathway: titration, discharge, home therapy, and follow-up and we provide technology, tools, accessories and software to integrate treatment into patients’ daily lives and help reduce the risk of hospital readmissions.”
The Cough-Trak algorithm within the device triggers a full cough upon every inspiration. Additionally, adjustable oscillation levels help in releasing mucus from the bronchial walls by applying vibrations to the airway.
To enhance patient mobility, the device is lightweight - weighing less than 4kg - and is compatible with an integrated detachable battery. An intuitive user interface with preset prescriptions simplifies setup and initiating therapy and new monitoring and data management tools allow for close follow-up at home, so that clinicians can assess therapy efficacy and adapt settings accordingly.